MedinCell S.A. (FRA:MEB)

Revenue by Product

Financials in millions EUR. Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Long-acting Injectable Drugs	9.03M
Long-acting Injectable Drugs Growth	-8.67%

Revenue by Geography

Financials in millions EUR. Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
France	9.03M
France Growth	-8.67%